Address:Building 11, Beishan Industrial Zone, Yantian District, Shenzhen(518083)


    About BGI

Curiosity, Application of Knowledge,
Working for the Betterment of Mankind.

Core Values

首页 About About BGI History



Actively prepared to participate in the Human Genome Project and closely followed and tracked scientific research in global human genomics.


With the advancement of sequencing technology, BGI's BT + IT scaled output model took shape. On September 9, 1999, BGI was established.

Synchronization / Beyond

The combination of big science and big data transformed into a large industry. In 2007, BGI went south to Shenzhen and completed a series of major scientific research projects, gradually moving from being a participant to being a leader.


In an unprecedented era of genetic industrialization, the development path of BGI moved from "scientific and technological cooperation" and "technical services" to "medical services", with a vision of using "genetics technology for the benefit of man

  • img1_1.jpg
    Yang Huanming, Yu Jun, Wang Jian and others proposed a set of forward-looking strategic ideas on China's participation in the Human Genome Project (HGP) in ZhangJiaJie, Hunan, which gave birth to the development and future of Chinese genomics.
  • img1_2.jpg
    BGI (now “BGI Group” or “BGI”) was established for the Human Genome Project.
  • img1_2.jpg
    The US NIH Dean visited BGI
  • img2_1.jpg
    BGI signed a contract to purchase 30 MegaBACE1000s.
  • img2_2.jpg
    Yuan Longping, Zhu Lihuang and Wang Jian jointly signed an agreement on the development of China's super hybrid rice genome research.
  • img2_3.jpg
    The Human Genome Project 1% project work framework was completed.
  • img2_4.jpg
    President Jiang Zemin pointed out that the Human Genome Project is a great scientific project in the history of human science and expressed gratitude to the Cinese scientists and technicians who participated in the work. “I hope that our scientists will continue to make greater contributions to the completion of the final research of the human genome and innovative research in genomics in China.”
  • img2_5.jpg
    The US "Science" magazine published a paper on the framework of the Chinese rice (Japonica) genome work in the form of a cover article.
  • img2_6.jpg
    For the first time in BGI, the whole genome sequence of four SARS viruses was deciphered. President Hu Jintao visited BGI and praised the researchers for "thinking what the central government thinks, caring for the urgency of the people, and developing what is needed to fight disease."
  • img2_7.jpg
    BGI donated 300,000 copies of the SARS virus diagnostic kit to the National Atypical Pneumonia Command.
  • img2_8.jpg
    The silkworm genome article was published in the American journal Science; the results of the chicken genome research were published in the journal Nature in the UK.
  • img2_9.jpg
    After the Indian Ocean tsunami, BGI FangRui dispatched a DNA identification and rescue team to the disaster area in Thailand to help with DNA identification of all the victims free of charge.
  • img2_10.jpg
    The Rice Genome Project “fine map” was completed.
  • img2_11.jpg
    The 10% International Human Genome HapMap Project (HapMap) undertaken by BGI and China Collaboration Group was published in Nature.
  • img3_1.jpg
    The first International Symposium on Genomics was held in Hangzhou.
  • img3_2.jpg
    BGI Research was established.
  • img3_3.jpg
    BGI participated in the post-disaster reconstruction of the “5·12 Wenchuan Earthquake” to monitor possible emergencies and infectious diseases.
  • img3_4.jpg
    BGI completed the sequencing of the giant panda genome.
  • img3_5.jpg
    The first Asian genome map ("Yanhuang No. 1") research results were published in the cover of the "Nature" magazine.
  • img3_6.jpg
    British "Nature" magazine published the results of the human intestinal bacteria genome research in the form of a cover article.
  • img3_7.jpg
    The results of the Tibetan Genome and Tibetan Genome Research were published in the journal Science.
  • img3_8.jpg
    BGI deciphered the pathogen genome of the German lethal E. coli outbreak and published the research results online in the internationally renowned magazine New England Medicine.
  • img4_1.jpg
    The Institute of Microbiology and Epidemiology of the Union Military Academy of Military Sciences and BGI successfully developed the Ebola virus nucleic acid detection reagent.
  • img4_2.jpg
    BGI teamed up with more than 20 scientists to complete the large-scale bird genome project, and 28 first-phase research results were published in magazines such as Science.
  • img4_3.jpg
    BGI released its first desktop high-throughput sequencing system, developed from proprietary technology, branded as the BGISEQ-500
  • img4_4.jpg
    BGI launched another self-developed high-throughput desktop sequencing system, BGISEQ-50.
  • img4_5.jpg
    Major achievements in the yeast genome synthesis project were published on the cover of the journal Science and Journal in the United States.
  • img4_6.jpg
    BGI Genomics stock code 300676) is listed on the Shenzhen Stock Exchange.
  • img4_7.jpg
    During the 12th International Symposium on Genomics (ICG-12), BGI officially released two high-throughput sequencing systems, MGISEQ-2000 and MGISEQ-200.
  • cell.jpg
    BGI published the largest ever study on Chinese Genomics in the world's top academic journal Cell.
  • T7.jpg
    During the 13th International Genomics Congress, BGI manufacturing (MGI )released its latest ultra-high-throughput gene sequencer, “MGISEQ-T7”.
  • 20200703112936971-2.jpg

    BGI published the research of 1520 reference genomes from cultivated human gut bacteria on Nature.

  • 20200703182359194.jpg
    BGI, together with Yunnan Agricultural University other institutions, announced the world's first high-quality chromosome-level genome of Spodoptera frugiperda.
  • 20200703182510601.jpg
    MGI released its self-developed new one-stop sequencing solution, including the brand new portable "express" sequencing system DNBSEQ E series, the modular "digital bio lab" DNBelab D series for use with the sequencing system.
  • 20200703182555698.jpg
    BGI participated in the comprehensive and large-scale genome project launched in Abu Dhabi, UAE. 
  • 20200703182639911.jpg
    BGI successfully developed the SARS-CoV-2 nucleic acid detection kits, and subsequently donated over 40,000 kits to the country.
  • 20200703182729763.jpg
    Both BGI Genomics SARS-CoV-2 nucleic acid detection kit and the MGI DNBSEQ-T7 Sequencing System have officially passed the emergency approval procedures of the National Medical Product Administration, becoming the first batch of COVID-19 testing products officially approved for the market.
  • 20200703182807674.jpg
    After the Huo-Yan Laboratory in Wuhan, operated by BGI, started to work, BGI has built Huo-Yan Laboratories in cities including Shenzhen, Tianjin and Beijing, to effectively assist local pandemic prevention and control efforts. Meanwhile, BGI helped to build Huo-Yan Laboratories in countries including Serbia, Brunei and the Philippines to help them to build up their capabilities in COVID-19 tests. 
  • th_20210508102200989.jpg.png
    The BGI Research, together with teams from Germany, Denmark and Belgium, discovered a new phylum-"Prasinodermophyta". This is the first discovery made by Chinese scientists in the category “phylum”.